Zhongzhu Healthcare Holding Co.,Ltd (SHA:600568)
2.720
+0.030 (1.12%)
Apr 29, 2026, 3:00 PM CST
SHA:600568 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 577.34 | 513.55 | 628.98 | 495.73 | 569.85 |
Other Revenue | - | 7.84 | 9.59 | 10.24 | 11.21 |
| 577.34 | 521.39 | 638.56 | 505.97 | 581.06 | |
Revenue Growth (YoY) | 10.73% | -18.35% | 26.21% | -12.92% | -20.13% |
Cost of Revenue | 473.84 | 572.71 | 694.98 | 396.08 | 456.43 |
Gross Profit | 103.5 | -51.32 | -56.42 | 109.89 | 124.63 |
Selling, General & Admin | 148.94 | 187.12 | 205.2 | 190.65 | 188.5 |
Research & Development | 12.16 | 11.96 | 16.18 | 18.21 | 24.68 |
Other Operating Expenses | 4.71 | 14.8 | 57.87 | 109.29 | 9.83 |
Operating Expenses | 165.82 | 223.72 | 275.24 | 322.26 | 234.2 |
Operating Income | -62.32 | -275.04 | -331.66 | -212.37 | -109.57 |
Interest Expense | - | -0.94 | -7.45 | -15 | -15.85 |
Interest & Investment Income | 1.66 | 5.72 | 25.44 | 24.43 | 20.14 |
Other Non Operating Income (Expenses) | -56.01 | -3.07 | -19.55 | -55.19 | -0.26 |
EBT Excluding Unusual Items | -116.66 | -273.33 | -333.22 | -258.13 | -105.55 |
Impairment of Goodwill | - | - | - | -26.73 | -68.7 |
Gain (Loss) on Sale of Investments | - | -333.77 | -5.61 | -248.67 | -3.28 |
Gain (Loss) on Sale of Assets | 9.87 | -0.38 | 26.01 | -0.66 | -2.67 |
Asset Writedown | -14.67 | -23.33 | -28.94 | -268.99 | -16.49 |
Legal Settlements | - | -0.64 | - | - | -0.45 |
Other Unusual Items | - | 4.15 | 3.37 | 1.83 | 9.69 |
Pretax Income | -121.46 | -627.3 | -338.4 | -801.34 | -187.45 |
Income Tax Expense | -8.51 | -2.13 | 0.02 | -9.56 | 21.06 |
Earnings From Continuing Operations | -112.94 | -625.17 | -338.41 | -791.78 | -208.51 |
Minority Interest in Earnings | -1.25 | 4.95 | -5.52 | -7.48 | -2.78 |
Net Income | -114.19 | -620.22 | -343.94 | -799.26 | -211.28 |
Net Income to Common | -114.19 | -620.22 | -343.94 | -799.26 | -211.28 |
Shares Outstanding (Basic) | 1,903 | 1,970 | 1,993 | 1,998 | 1,993 |
Shares Outstanding (Diluted) | 1,903 | 1,970 | 1,993 | 1,998 | 1,993 |
Shares Change (YoY) | -3.40% | -1.13% | -0.27% | 0.25% | -0.92% |
EPS (Basic) | -0.06 | -0.31 | -0.17 | -0.40 | -0.11 |
EPS (Diluted) | -0.06 | -0.31 | -0.17 | -0.40 | -0.11 |
Free Cash Flow | 24 | 19.81 | -24.49 | -0.43 | 31.04 |
Free Cash Flow Per Share | 0.01 | 0.01 | -0.01 | - | 0.02 |
Gross Margin | 17.93% | -9.84% | -8.84% | 21.72% | 21.45% |
Operating Margin | -10.79% | -52.75% | -51.94% | -41.97% | -18.86% |
Profit Margin | -19.78% | -118.96% | -53.86% | -157.97% | -36.36% |
Free Cash Flow Margin | 4.16% | 3.80% | -3.84% | -0.08% | 5.34% |
EBITDA | -3.95 | -210.97 | -265.24 | -135.21 | -32.43 |
EBITDA Margin | -0.68% | -40.46% | -41.54% | -26.72% | -5.58% |
D&A For EBITDA | 58.37 | 64.07 | 66.42 | 77.16 | 77.14 |
EBIT | -62.32 | -275.04 | -331.66 | -212.37 | -109.57 |
EBIT Margin | -10.79% | -52.75% | -51.94% | -41.97% | -18.86% |
Revenue as Reported | - | 521.39 | 638.56 | 505.97 | 581.06 |
Advertising Expenses | - | 1.81 | 1.17 | 2.13 | 3.34 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.